Prognostic and predictive value of mRNA expression of mTOR and VEGF pathway members in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Nosov, Dmitry
Voroshilova, Ekaterina
Apanovich, Natalya
Fedyanin, Mikhail
Karpukhin, Alexander
机构：
[1] NN Blokhin Canc Res Ctr, Dept Clin Pharmacol & Chemotherapy, Moscow, Russia
[2] Canc Res Ctr, Moscow, Russia
[3] Med Genet Res Ctr, Moscow, Russia
[4] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e16130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16130
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
    Liontos, Michalis
    Trigka, Eleni-Andriana
    Korkolopoulou, Penelope
    Tzannis, Kimon
    Lainakis, Giorgos
    Koutsoukos, Konstantinos
    Kostouros, Efthymios
    Lykka, Maria
    Papandreou, Christos N.
    Karavasilis, Vassilis
    Christodoulou, Christos
    Papatsoris, Athanasios
    Skolarikos, Andreas
    Varkarakis, Ioannis
    Adamakis, Ioannis
    Alamanis, Christos
    Stravodimos, Konstantinos
    Mitropoulos, Dionysios
    Deliveliotis, Charalambos
    Constantinidis, Constantinos A.
    Saetta, Angelica
    Patsouris, Efstratios
    Dimopoulos, Meletios I.
    Bamias, Aristotelis
    WORLD JOURNAL OF UROLOGY, 2017, 35 (03) : 411 - 419
  • [2] Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
    Michalis Liontos
    Eleni-Andriana Trigka
    Penelope Korkolopoulou
    Kimon Tzannis
    Giorgos Lainakis
    Konstantinos Koutsoukos
    Efthymios Kostouros
    Maria Lykka
    Christos N. Papandreou
    Vassilis Karavasilis
    Christos Christodoulou
    Athanasios Papatsoris
    Andreas Skolarikos
    Ioannis Varkarakis
    Ioannis Adamakis
    Christos Alamanis
    Konstantinos Stravodimos
    Dionysios Mitropoulos
    Charalambos Deliveliotis
    Constantinos A. Constantinidis
    Angelica Saetta
    Efstratios Patsouris
    Meletios Α. Dimopoulos
    Aristotelis Bamias
    World Journal of Urology, 2017, 35 : 411 - 419
  • [3] PREDICTIVE VALUE OF TIME TO BEST RESPONSE FOR EFFICACY MTOR INHIBITORS (MTORI) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS)
    Elaidi, R. T.
    Teghom, C.
    Comte, A.
    Jebali, M.
    Fouque, J.
    Medioni, J.
    Oudard, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 282 - 282
  • [4] Early tumor shrinkage (eTS) as a predictive and prognostic factor in metastatic renal cell carcinoma (mRCC).
    Gruenwald, Viktor
    Lin, Xun
    Kalanovic, Daniel
    Simantov, Ronit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Targeted therapies (TTs) in metastatic renal cell carcinoma (MRCC): Role of metastatic site as a prognostic and predictive factor
    Procopio, G.
    Grassi, P.
    Porcu, L.
    Verzoni, E.
    Testa, I.
    Garanzini, E.
    Biondani, P.
    Pusceddu, S.
    De Braud, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S666 - S666
  • [6] Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas
    Schultz, Luciana
    Chaux, Alcides
    Albadine, Roula
    Hicks, Jessica
    Kim, Jenny J.
    De Marzo, Angelo M.
    Allaf, Mohamad E.
    Carducci, Michael A.
    Rodriguez, Ronald
    Hammers, Hans-Joerg
    Argani, Pedram
    Reuter, Victor E.
    Netto, George J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (10) : 1549 - 1556
  • [7] Prognostic Value of the mRNA Expression of Members of the Toll-like Receptor Family in Clear Cell Renal Cell Carcinoma
    Sabah-Ozcan, Seda
    Hacisalihoglu, Payam
    Yanik, Serdar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2019, 18 (04): : 149 - 153
  • [8] Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).
    Luo, Jia
    Podolak, Jennifer
    Degnin, Catherine
    Chen, Yiyi
    Robinson, Kyle William
    Pukay, Marina
    Schilling, Amy
    Poage, Cara
    Thomas, George V.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).
    Zurita, Amado J.
    Danziger, Natalie
    Scott, Takara
    Gjoerup, Ole
    Zhong, Lei
    Tukachinsky, Hanna
    Ross, Jeffrey S.
    Graf, Ryon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 455 - 455
  • [10] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
12345